Jogy George

FDA investigator

Appears on 15 documents from 2016 to 2023, most often at sites in India. Most often cites written procedures; deviations (21 CFR 211.100).

15
Documents on file
4.8
Observations per 483
2016
First seen
2023
Most recent

What they cite most

From 72 observations

Activity by year

2016: 2, 2017: 3, 2018: 1, 2019: 4, 2020: 2, 2022: 2, 2023: 1

Where

India 7 · New Jersey 6 · Florida 2

Is Jogy George coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 Naari Pharma Private LimitedJan 27, 2023 · Rudrapur, India
483 Amneal Pharmaceuticals, LLCNov 18, 2022 · Branchburg, New Jersey
483 Innovation Labs, Inc.Jul 5, 2022 · Mahwah, New Jersey
483 Speciality Pharma Manufacturing, LLCMar 16, 2020 · Carlstadt, New Jersey
483 Aurolife Pharma LLCFeb 12, 2020 · Dayton, New Jersey
483 Aurobindo Pharma LimitedSep 27, 2019 · Polepally, India
483 Aurobindo Pharma Limited Unit VII, Formulation Plant, Plot §-1Sep 27, 2019 · Polepally, India

About this profile

What does Jogy George inspect?

Jogy George appears on 15 documents on file covering 14 sites, most often in India.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jogy George is dated Jan 27, 2023.